Researchers have uncovered a previously unknown mechanism that helps cancer cells evade detection by the body’s immune system. The findings could potentially lead to the development of more effective cancer immunotherapies.

Researchers have discovered a molecular mechanism that regulates whether the cells of an aggressive colorectal cancer are conventional or inverted when they spread in the body. The discovery can help identify patients who have an elevated risk that the cancer metastasises to the abdominal cavity.

A study has revealed that mindfulness and tai chi practices eased sleep problems, fatigue, and pain of patients post their cancer treatment.

Researchers have developed a method to analyze blood samples with just 5 % cancer DNA, compared to the 15–20 % required today—opening the door to improved cancer care and tumor monitoring.

A recent study has revealed that valvular heart disease is common in cancer patients and that interventions to treat this disease significantly improved survival.

Cancer patients often face the added challenge of heart-related side effects, which can force discontinuation of anticancer therapy and reduce its effectiveness. Researchers recently presented findings on the protective effects of medical therapies recommended to treat heart failure.

Scientists have revealed that a highly sensitive blood test can now detect traces of pancreatic cancer that are missed by standard testing. The simple test can help identify patients whose disease is more likely to return even when scans appear reassuring.

A University of Rochester team has hit a key FDA milestone for “organs on a chip” technology that predicts dangerous side effects of cancer immunotherapies using real human cells, no animal models required.

Scientists have revealed that a drug that is widely used to treat asthma and allergies may also help fight aggressive cancers. The findings suggest that it is a new way to improve treatment for tough tumors, such as triple-negative breast cancer, where immunotherapy often fails.

The ‘Cardiocare’ project is focusing on a vulnerable group of patients – women over 65 with breast cancer at risk of cardiotoxicity from cancer treatment. The project is currently celebrating a series of major achievements that bring its ambitious vision closer to reality: smarter, more personalized and more patient-centered care for this patient group.